Global X HealthTech ETF (NASDAQ:HEAL) Sees Significant Drop in Short Interest

Global X HealthTech ETF (NASDAQ:HEAL) was the target of a large decline in short interest in July. As of July 31st, there was short interest totaling 7,620 shares, a decline of 66.5% from the July 15th total of 22,725 shares. Approximately 0.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 8,615 shares, the days-to-cover ratio is presently 0.9 days.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Banque Cantonale Vaudoise bought a new position in Global X HealthTech ETF in the third quarter valued at $37,000. Glenmede Investment Management LP bought a new position in shares of Global X HealthTech ETF during the 3rd quarter valued at about $31,000. Daiwa Securities Group Inc. purchased a new position in shares of Global X HealthTech ETF during the 3rd quarter valued at about $11,239,000. Raymond James Financial Inc. purchased a new position in shares of Global X HealthTech ETF during the 3rd quarter valued at about $274,000. Finally, Citadel Advisors LLC bought a new stake in Global X HealthTech ETF in the 3rd quarter worth approximately $216,000.

Global X HealthTech ETF Price Performance

NASDAQ HEAL traded up $0.24 during trading on Friday, reaching $29.42. The company’s stock had a trading volume of 1,945 shares, compared to its average volume of 10,590. The firm has a fifty day moving average of $27.36 and a 200 day moving average of $26.16. The stock has a market capitalization of $31.19 million, a PE ratio of 42.80 and a beta of 1.10. Global X HealthTech ETF has a one year low of $23.00 and a one year high of $33.59.

About Global X HealthTech ETF

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.